​

Illumina (ILMN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ILMN Stock Forecast

Illumina (ILMN) stock forecast, based on 50 Wall Street analysts, predicts a 12-month average price target of $147.13, with a high of $170.00 and a low of $110.00. This represents a 27.32% increase from the last price of $115.56.

$100 $114 $128 $142 $156 $170 High: $170 Avg: $147.13 Low: $110 Last Closed Price: $115.56

ILMN Stock Rating

Illumina stock's rating consensus is Buy, based on 50 Wall Street analysts. The breakdown includes 1 Strong Buy (2.00%), 24 Buy (48.00%), 19 Hold (38.00%), 6 Sell (12.00%), and 0 Strong Sell (0.00%).

Buy
Total 50 6 19 24 1 Strong Sell Sell Hold Buy Strong Buy

ILMN Price Target Upside V Benchmarks

TypeNameUpside
StockIllumina27.32%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks34.89%

Price Target Trends

1M3M12M
# Anlaysts-1022
Avg Price Target-$147.60$130.36
Last Closing Price$115.56$115.56$115.56
Upside/Downside-27.73%12.81%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 261881220
Feb, 261781219
Jan, 261781219
Dec, 251791220
Nov, 251791220
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 09, 2026Piper Sandler$170.00$119.7242.00%47.11%
Feb 06, 2026Catherine Ramsey SchulteRobert W. Baird$137.00$120.2213.96%18.55%
Feb 06, 2026UBS$135.00$121.2711.32%16.82%
Feb 06, 2026Evercore ISI$150.00$121.1323.83%29.80%
Jan 26, 2026Subbu NambiGuggenheim$170.00$150.3813.05%47.11%
Jan 26, 2026Canaccord Genuity$150.00$150.28-0.19%29.80%
Jan 20, 2026Daniel AriasStifel Nicolaus$155.00$141.659.42%34.13%
Jan 05, 2026Vijay KumarEvercore ISI$155.00$138.5011.91%34.13%
Jan 05, 2026Guggenheim$144.00$138.114.26%24.61%
Dec 15, 2025Barclays$110.00$134.85-18.43%-4.81%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 06, 2026UBSNeutralNeutralhold
Jan 26, 2026GuggenheimBuyBuyhold
Jan 07, 2026Cowen & Co.HoldHoldhold
Jan 05, 2026Evercore ISIOutperformOutperformhold
Jan 05, 2026GuggenheimBuyBuyhold
Dec 15, 2025BarclaysUnderweightUnderweighthold
Oct 31, 2025Evercore ISIOutperformOutperformhold
Oct 31, 2025Cowen & Co.HoldHoldhold
Oct 31, 2025UBSNeutralNeutralhold
Oct 31, 2025BarclaysUnderweightUnderweighthold

Financial Forecast

EPS Forecast

$-30 $-22 $-14 $-6 $2 $10 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.08$-28.05$-7.35$-7.69$5.47---
Avg Forecast$5.56$2.23$0.73$4.12$4.44$5.15$5.85$6.61
High Forecast$5.65$2.29$0.87$4.13$4.58$6.35$7.43$6.67
Low Forecast$5.44$2.18$0.62$4.09$4.33$3.56$4.75$6.53
Surprise %-8.63%-1357.85%-1106.85%-286.65%23.20%---

Revenue Forecast

$4B $5B $5B $5B $5B $5B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$4.53B$4.58B$4.50B$4.37B$4.34B---
Avg Forecast$4.45B$4.57B$4.46B$4.33B$4.44B$4.68B$4.98B$5.25B
High Forecast$4.51B$4.67B$4.49B$4.36B$4.47B$4.69B$4.99B$5.29B
Low Forecast$4.38B$4.49B$4.44B$4.32B$4.40B$4.67B$4.96B$5.20B
Surprise %1.66%0.24%0.88%0.92%-2.16%---

Net Income Forecast

$-5B $-3B $-2B $-900M $300M $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$762.00M$-4.40B$-1.16B$-1.22B$850.00M---
Avg Forecast$878.46M$554.35M$-1.16B$649.63M$704.41M$679.88M$841.27M$1.04B
High Forecast$892.13M$665.22M$-928.80M$652.79M$724.31M$1.00B$1.17B$1.05B
Low Forecast$860.23M$443.48M$-1.39B$646.47M$684.51M$562.33M$750.97M$1.03B
Surprise %-13.26%-894.45%--288.26%20.67%---

ILMN Forecast FAQ

Is Illumina stock a buy?

Illumina stock has a consensus rating of Buy, based on 50 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 24 Buy, 19 Hold, 6 Sell, and 0 Strong Sell, reflecting a consensus that Illumina is a favorable investment for most analysts.

What is Illumina's price target?

Illumina's price target, set by 50 Wall Street analysts, averages $147.13 over the next 12 months. The price target range spans from $110 at the low end to $170 at the high end, suggesting a potential 27.32% change from the previous closing price of $115.56.

How does Illumina stock forecast compare to its benchmarks?

Illumina's stock forecast shows a 27.32% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the diagnostics & research stocks industry (34.89%).

What is the breakdown of analyst ratings for Illumina over the past three months?

  • March 2026: 5.00% Strong Buy, 40.00% Buy, 40.00% Hold, 5.00% Sell, 10.00% Strong Sell.
  • February 2026: 5.26% Strong Buy, 36.84% Buy, 42.11% Hold, 5.26% Sell, 10.53% Strong Sell.
  • January 2026: 5.26% Strong Buy, 36.84% Buy, 42.11% Hold, 5.26% Sell, 10.53% Strong Sell.

What is Illumina’s EPS forecast?

Illumina's average annual EPS forecast for its fiscal year ending in December 2026 is $5.15, marking a -5.85% decrease from the reported $5.47 in 2025. Estimates for the following years are $5.85 in 2027, and $6.61 in 2028.

What is Illumina’s revenue forecast?

Illumina's average annual revenue forecast for its fiscal year ending in December 2026 is $4.68B, reflecting a 7.82% increase from the reported $4.34B in 2025. The forecast for 2027 is $4.98B, and $5.25B for 2028.

What is Illumina’s net income forecast?

Illumina's net income forecast for the fiscal year ending in December 2026 stands at $679.88M, representing a -20.01% decrease from the reported $850M in 2025. Projections indicate $841.28M in 2027, and $1.04B in 2028.